Rhonda L. Stanley
Keine laufenden Positionen mehr
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Andrew Kucharchuk | M | 43 | 4 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Jeryl Hilleman | F | 67 | 1 Jahre | |
| John Hamill | M | 60 | 3 Jahre | |
| Vipin K. Garg | M | 67 | 13 Jahre | |
| Eckard Weber | M | 73 | - | |
| Nancy Phelan | F | 55 | 2 Jahre | |
| Sheila Mikhail | F | 57 |
Bamboo Therapeutics, Inc.
 Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | 2 Jahre |
| Franck S. Rousseau | M | 67 | 1 Jahre | |
| Nina Kjellson | F | 49 | 4 Jahre | |
| Erik Emerson | M | 53 | 2 Jahre | |
| Timothy Boris | M | 55 | 2 Jahre | |
| Donald Williams | M | 65 | 5 Jahre | |
| Dana S. McGowan | F | - | - | |
| Marco Taglietti | M | 64 | 3 Jahre | |
| Richard Eisenstadt | M | 66 | 9 Jahre | |
| Isaac Blech | M | 73 | 2 Jahre | |
| Gordana Košutic | M | 73 | 6 Jahre | |
| George Abercrombie | M | 69 | 2 Jahre | |
| Helmut Thomas | M | 72 | 7 Jahre | |
| Brenda D. Gavin | M | 76 | 6 Jahre | |
| Michael Powell | M | 69 | 4 Jahre | |
| Wendell Wierenga | M | 76 | 4 Jahre | |
| Anne VanLent | F | 76 | 6 Jahre | |
| John Johnson | M | 66 | 3 Jahre | |
| Dan Cabo | M | - | 7 Jahre | |
| Martin Vogelbaum | M | 60 | 1 Jahre | |
| Anne F. McKay | F | - | - | |
| David S. Moore | M | 50 | 2 Jahre | |
| Kenneth Ruettimann | M | - | - | |
| Brent Bankosky | M | - | - | |
| Jak Knowles | M | - |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | 1 Jahre |
| L. Smith | M | 57 |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | 1 Jahre |
| Paul Herzich | M | 46 |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 33 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Rhonda L. Stanley
- Persönliches Netzwerk